Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cogent Biosciences (COGT) Revenue (2017 - 2020)

Cogent Biosciences' Revenue history spans 4 years, with the latest figure at $312000.0 for Q3 2020.

  • Quarterly Revenue fell 69.41% to $312000.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $7.9 million through Dec 2020, down 65.02% year-over-year, with the annual reading at $7.9 million for FY2020, 65.02% down from the prior year.
  • Revenue came in at $312000.0 for Q3 2020, down from $528000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $15.3 million in Q4 2019 to a low of $312000.0 in Q3 2020.
  • The 4-year median for Revenue is $2.1 million (2017), against an average of $3.2 million.
  • Year-over-year, Revenue soared 301.79% in 2019 and then tumbled 83.17% in 2020.
  • Cogent Biosciences' Revenue stood at $2.1 million in 2017, then skyrocketed by 79.23% to $3.8 million in 2018, then skyrocketed by 301.79% to $15.3 million in 2019, then crashed by 97.96% to $312000.0 in 2020.
  • Per Business Quant, the three most recent readings for COGT's Revenue are $312000.0 (Q3 2020), $528000.0 (Q2 2020), and $7.0 million (Q1 2020).